Ardelyx (ARDX) 10-K2021 FY Annual report

Filed: 28 Feb 22, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accident, ADL, Alabama, AMP, analyst, appeal, argued, began, begun, bid, BP, canceled, Cardiology, Carolina, ceiling, Central, certainty, Cincinnati, CJEU, clause, clear, COBRA, comfortable, compelling, concept, conclusion, conclusive, Connecticut, convincing, copyright, counsel, counter, decade, deceptive, deep, deprive, differentiated, disbursed, discretionary, dismissed, dispensed, disproportionate, dropping, DTC, eighty, Endocrinology, entirety, Ernst, EU, exceeded, excise, explanatory, FDR, FDRR, formula, FSS, GCC, Guard, Hematology, HRSA, ID, Idaho, incomplete, incorrect, Indian, infection, inpatient, instructed, intentionally, inter, invited, inviting, invoked, Kentucky, lag, lifespan, LLP, Maineville, MDRP, merit, military, Mississippi, Missouri, MO, Nebraska, negate, occupy, OCHEN, OHCEN, Oklahoma, OND, online, onset, output, outweigh, overcharge, overcome, path, Pennsylvania, pharmacovigilance, plaintiff, PMDA, presumption, proof, quick, rebuild, recalculation, reconsider, reexamination, reexamining, refinancing, regain, reopened, reorganization, Rescue, resubmission, resubmit, RX, RXs, safest, sixty, SLR, statutorily, thought, trailing, treatable, TRICARE, triple, untimely, VA, Virginia, write, writing, XPHOZAH, Young, Zealand

Removed: absence, adherence, advocacy, alternate, amplify, applying, Ardenwood, arm, aspect, attained, attractive, baseline, Blvd, CA, CAD, cardiovascular, cGCP, clinic, collusion, colonic, Colonocyte, compromised, convenience, deny, denying, desirable, detected, digit, diligence, disagree, discomfort, distention, dosed, ease, educating, element, emulate, enhance, Enterocyte, eroding, excluded, exerted, expenditure, fluid, format, function, greatly, harmful, idiopathic, insolvency, judicially, meal, miniaturized, modify, narrative, nausea, negligible, object, optimal, Oregon, override, owe, pipeline, prefer, quickly, ratio, recruitment, relevance, rendering, replace, representative, retrospectively, reveal, rulemaking, screening, select, show, sooner, stage, statistical, statistically, stem, studied, succeed, tract, traditional, Trump, twenty, UNAUDITED, unpredictability, unutilized, vomiting, warrant, wrong

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated ARDX transcripts

ARDX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Ardelyx, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Michael Raab, President and Chief Executive Officer of the Company, and Justin Renz, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Date: February 28, 2022	By:	/s/ Michael Raab
		Michael Raab President, Chief Executive Officer and Director (Principal Executive Officer)


Date: February 28, 2022	By:	/s/ Justin Renz
		Justin Renz Chief Financial Officer (Principal Financial Officer)